This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Doris, P. A. Search for Related Content PubMed PubMed Citation Articles by Doris, P. A. Pubmed/NCBI databases Medline Plus Health Information High Blood Pressure

(Hypertension. 2002;39:323.)
© 2002 American Heart Association, Inc.

Workshops

Hypertension Genetics, Single Nucleotide Polymorphisms, and the Common Disease:Common Variant Hypothesis

Peter A. Doris

From the Center for Human Genetics, Institute of Molecular Medicine, University of Texas at Houston

Correspondence to Dr Peter Doris, Institute of Molecular Medicine, University of Texas at Houston, 2121 W. Holcombe Blvd, Houston, TX 77030. E-mail Peter.A.Doris{at}uth.tmc.edu

Abstract

The investigation of heritable susceptibility to disease is an effort to associate disease phenotype with underlying genotype. Such genotype:phenotype associations have been demonstrated for a large number of monogenetic disorders. The usual strategy has been to use linkage mapping in affected families to identify chromosomal loci from which candidate genes and genotypes can be tested for association with disease. This strategy has not been similarly successful for common heritable disease susceptibilities including hypertension that involve multiple genes and gene-environment interactions. Development of extensive collections of single nucleotide polymorphisms (SNPs) raises the possibility that these SNPs can be used as markers in genome-wide association mapping studies to identify hypertension susceptibility loci. In this approach, large numbers of markers are typed in cases and controls with the expectation that markers interrogating SNPs that are involved in inheritance of disease susceptibility will emerge through their association with this trait in the affected population. Essential hypertension is a common disorder. The term "common" has 2 implications: first, that the disease is prevalent; and, second, that it is widespread. Such frequency and distribution characteristics could arise if the susceptibility alleles for hypertension were prevalent in the founding population of contemporary human beings and became distributed with human global dispersal. This common disease:common variant concept is attractive because it suggests that the genetic heterogeneity underlying hypertension susceptibility could be relatively small. It also allows the possibility that nonrandom association of alleles (linkage disequilibrium, LD) can be used to reduce the number of SNP markers required to identify disease susceptibility alleles because a single marker can act as a surrogate for variation flanking it. The influence of a number of important factors on the detectability of hypertension susceptibility alleles by SNP mapping approaches is not yet fully defined. These factors include the locus and allelic diversity of hypertension, the weaker relationship (compared with Mendelian traits) between genotype and phenotype, the accuracy of high throughput genotyping techniques, the extensive role of nongenetic factors, and the extent and heterogenous nature of LD across the genome.

Key Words: hypertension, essential • genes • epidemiology • polymorphism

This article has been cited by other articles:

				K. Mussig, H. Staiger, F. Machicao, A. Stancakova, J. Kuusisto, M. Laakso, C. Thamer, J. Machann, F. Schick, C. D. Claussen, et al. Association of Common Genetic Variation in the FOXO1 Gene with {beta}-Cell Dysfunction, Impaired Glucose Tolerance, and Type 2 Diabetes J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1353 - 1360. [Abstract] [Full Text] [PDF]

				J.-B. Zhou and J.-K. Yang Meta-analysis of association of ACE2 G8790A polymorphism with Chinese Han essential hypertension Journal of Renin-Angiotensin-Aldosterone System, March 1, 2009; 10(1): 31 - 34. [Abstract] [PDF]

				D. K. Arnett, A. E. Baird, R. A. Barkley, C. T. Basson, E. Boerwinkle, S. K. Ganesh, D. M. Herrington, Y. Hong, C. Jaquish, D. A. McDermott, et al. Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease: A Scientific Statement From the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group Circulation, June 5, 2007; 115(22): 2878 - 2901. [Abstract] [Full Text] [PDF]

				S. K. Iyengar The Quest for Genes Causing Complex Traits in Ocular Medicine: Successes, Interpretations, and Challenges Arch Ophthalmol, January 1, 2007; 125(1): 11 - 18. [Abstract] [Full Text] [PDF]

				O. Gumieniak, S. Hurwitz, T. S. Perlstein, U. C. Ngumezi, P. N. Hopkins, X. Jeunemaitre, and G. H. Williams Aggregation of High-Normal Thyroid-Stimulating Hormone in Hypertensive Families J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5985 - 5990. [Abstract] [Full Text] [PDF]

				C. A. Hinojos, E. Boerwinkle, M. Fornage, and P. A. Doris Combined Genealogical, Mapping, and Expression Approaches to Identify Spontaneously Hypertensive Rat Hypertension Candidate Genes Hypertension, April 1, 2005; 45(4): 698 - 704. [Abstract] [Full Text] [PDF]

				P. Sankar, M. K. Cho, C. M. Condit, L. M. Hunt, B. Koenig, P. Marshall, S. S.-J. Lee, and P. Spicer Genetic Research and Health Disparities JAMA, June 23, 2004; 291(24): 2985 - 2989. [Abstract] [Full Text] [PDF]

				F. C. Luft Geneticism of Essential Hypertension Hypertension, June 1, 2004; 43(6): 1155 - 1159. [Full Text] [PDF]

				G. Gong, O. Kosoko-Lasaki, G. R. Haynatzki, and M. R. Wilson Genetic dissection of myocilin glaucoma Hum. Mol. Genet., April 1, 2004; 13(90001): R91 - 102. [Abstract] [Full Text] [PDF]

				T. Forrester Historic and Early Life Origins of Hypertension in Africans J. Nutr., January 1, 2004; 134(1): 211 - 216. [Abstract] [Full Text] [PDF]

				V. Dzau Risk assessment in cardiovascular disease: from traditional risk factors to genomics Eur. Heart J. Suppl., August 1, 2003; 5(suppl_F): F48 - F55. [Abstract] [PDF]

				R. S. Cooper and B. M. Psaty Genomics and Medicine: Distraction, Incremental Progress, or the Dawn of a New Age? Ann Intern Med, April 1, 2003; 138(7): 576 - 580. [Abstract] [Full Text] [PDF]

				L. J. Palmer Loosening the Cuff: Important New Advances in Modeling Antihypertensive Treatment Effects in Genetic Studies of Hypertension Hypertension, February 1, 2003; 41(2): 197 - 198. [Full Text] [PDF]

				B. Hasimu, T. Nakayama, Y. Mizutani, Y. Izumi, S. Asai, M. Soma, S. Kokubun, and Y. Ozawa Haplotype Analysis of the Human Renin Gene and Essential Hypertension Hypertension, February 1, 2003; 41(2): 308 - 312. [Abstract] [Full Text] [PDF]

				D. J. Smith and A. J. Lusis The allelic structure of common disease Hum. Mol. Genet., October 1, 2002; 11(20): 2455 - 2461. [Abstract] [Full Text] [PDF]